Giesing Dennis H 4
4 · Immunome Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Giesing Dennis H
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-16+60,000→ 60,000 totalExercise: $3.42Exp: 2032-06-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]With respect to the options to purchase 30,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024.